Kuros Biosciences AG (ETR:YTSN)
Germany
· Delayed Price · Currency is EUR 28.44
0.00 (0.00%)
At close: Aug 15, 2025, 5:30 PM CET
Kuros Biosciences AG Revenue
Kuros Biosciences AG had revenue of 63.48M CHF in the half year ending June 30, 2025, with 393.39% growth. This brings the company's revenue in the last twelve months to 103.35M, up 129.81% year-over-year. In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M with 125.11% growth.
Revenue (ttm)
103.35M CHF
Revenue Growth
+129.81%
P/S Ratio
9.92
Revenue / Employee
847.14K CHF
Employees
122
Market Cap
1.10B EUR
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
| Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
| Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
| Dec 31, 2021 | 13.82M | 9.78M | 242.04% |
| Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Energy AG | 38.39B |
| Rheinmetall AG | 10.67B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Deutsche Bank Aktiengesellschaft | 30.07B |